DiaMedica Therapeutics (NASDAQ:DMAC) Posts Quarterly Earnings Results : vimarsana.com

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) posted its quarterly earnings results on Tuesday. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14), Yahoo Finance reports. During the same quarter in the previous year, the company earned ($0.10) EPS. DiaMedica Therapeutics Stock Performance DMAC stock opened at $1.52 on Wednesday. The […]

Related Keywords

, Dimensional Fund Advisors , Citadel Advisors , Renaissance Technologies , Yahoo , Diamedica Therapeutics Company Profile , Diamedica Therapeutics Inc , Diamedica Therapeutics , Get Rating , Yahoo Finance , Medica Therapeutics , Street Group , Fund Advisors , State Street Corp , Street Corp , Wayne Lautt , Diamedica Therapeutics Daily , Nasdaq Dmac , Sdmac , Medical , Earnings ,